All In Biotech

Drug Trial Radar · NCT06106828

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease

A Phase III, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Moderate-to-Severe Thyroid Eye Disease

Last checked: Nov 20, 2026Latest source record: Aug 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 127 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

127

Actual

Start

Nov 15, 2023

Primary completion

Jul 24, 2025

Study completion Jun 25, 2026

Sponsor

Lead sponsor
Hoffmann-La RocheRoche (Genentech) (RHHBY)
Sponsor type
Industry
First posted
Oct 30, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the efficacy, safety, pharmacokinetics, and pharmacodynamics of subcutaneous (SC) satralizumab, a recombinant, humanized anti-interleukin-6 (IL-6) receptor monoclonal antibody, in participants with thyroid eye disease (TED).

Conditions

  • Thyroid Eye Disease

Interventions

  • SatralizumabDrug

    Satralizumab will be administered by SC injection.

  • PlaceboDrug

    Placebo will be administered by SC injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants in the Active TED Population Who Achieved ≥ 2 Millimeters (mm) Reduction in Proptosis From Baseline at Week 24 in the Study EyeTime frame: At Week 24

Locations

41 sites in 10 countries. Site status is shown where the registry gives one.

  • Plastics-Orbit-Neuro

    San Diego, California

  • Connecticut Eye Consultants, P.C.

    Danbury, Connecticut

  • University of Illinois Eye and Ear Infirmary

    Chicago, Illinois

  • Scheie Eye Institute

    Philadelphia, Pennsylvania

  • Vanderbilt Eye Institute

    Nashville, Tennessee

  • Retina Consultants of Texas

    San Antonio, Texas

  • University of Alberta

    Edmonton, Alberta, Canada

  • Toronto Retina Institute

    Toronto, Ontario, Canada

  • Universite de Montreal - Hopital Maisonneuve-Rosemont

    Montreal, Quebec, Canada

  • Peking Union Medical College Hospital

    Beijing, China

  • Peking University Third Hospital

    Beijing, China

  • Beijing Hospital of Ministry of Health

    Beijing, China

  • Beijing Tongren Hospital, Capital Medical University

    Beijing, China

  • Xi'an Fourth Hospital

    Xi'an, China

  • CHU Nantes - Hotel Dieu

    Nantes, France

  • CHNO Hopital des Quinze Vingts

    Paris, France

  • Fondation Rothschild

    Paris, France

  • Hadassah MC

    Jerusalem, Israel

  • Rabin MC

    Petah Tikva, Israel

  • Sheba medical center

    Ramat Gan, Israel

  • Specjalistyczny Osrodek Okulistyczny Oculomedica

    Bydgoszcz, Poland

  • Profesorskie Centrum Medyczne Spolka Z Ograniczona Odpowiedzialnoscia

    Gdansk, Poland

  • AIBILI - Association for Innovation and Biomedical Research on Light

    Coimbra, Portugal

  • Seoul National University Bundang Hospital

    Seongnam-si, South Korea

  • Severance Hospital, Yonsei University Health System

    Seoul, South Korea

  • Chung-Ang University Hospital

    Seoul, South Korea

  • Samsung Medical Center

    Seoul, South Korea

  • Hospital Universitario Vall d Hebron

    Barcelona, Spain

  • Hospital Universitario Virgen de las Nieves

    Granada, Spain

  • Hospital Ramon y Cajal

    Madrid, Spain

  • Hospital Universitario Clínico San Carlos

    Madrid, Spain

  • Hospital Universitario Virgen de la Macarena

    Seville, Spain

  • Hospital Universitario la Fe: Servicio de Oftalmologia

    Valencia, Spain

  • Hospital Universitari de Bellvitge

    L'Hospitalet de Llobregat, Barcelona, Spain

  • Sussex Eye Hospital

    Brighton, United Kingdom

  • Bristol Eye Hospital

    Bristol, United Kingdom

  • Gartnavel General Hospital

    Glasgow, United Kingdom

  • St James University Hospital

    Leeds, United Kingdom

  • Royal Liverpool University Hospital

    Liverpool, United Kingdom

  • Moorfields Eye Hospital NHS Foundation Trust

    London, United Kingdom

Showing 40 of 41 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.